Syed Ali
Family Medicine · Peoria, ILNPI 1700805439
Payments from drug & device makers
Across 77 payments — averaging $26.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$354
- AbbVie$350
- AstraZeneca$306
- Astellas Pharma US Inc$207
- Teva Pharmaceuticals USA, Inc.$128
- Pfizer$122
- plus $572 from 13 others
What the payments were for
- Food & beverage$1,96396%
- Education$754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $354 |
| AbbVie | 21 | $350 |
| AstraZeneca | 7 | $306 |
| Astellas Pharma US Inc | 3 | $207 |
| Teva Pharmaceuticals USA, Inc. | 8 | $128 |
| Pfizer | 1 | $122 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $113 |
| Eisai Inc. | 1 | $90 |
| Biohaven Pharmaceuticals, Inc. | 4 | $74 |
| Esperion Therapeutics, Inc. | 4 | $59 |
| Ascend Therapeutics US, LLC | 2 | $50 |
| Lilly USA, LLC | 3 | $46 |
| Nestle Healthcare Nutrition Inc. | 2 | $36 |
| Evofem Biosciences, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Coopersurgical, Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$242
- ELIQUIS$122
- Veozah$117
- NURTEC ODT$113
- AIMOVIG$112
How this compares
$2,038 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $12,698 |
| Levothyroxine Sodium | 44 | $1,109 |
| Losartan Potassium | 45 | $644 |
| Simvastatin | 44 | $595 |
| Omeprazole | 35 | $533 |
| FenofibrateFenofibrate,micronized | 13 | $346 |
| Rosuvastatin Calcium | 15 | $296 |
| Amlodipine Besylate | 38 | $271 |
| Pantoprazole Sodium | 19 | $229 |
| Allopurinol | 30 | $222 |
| Montelukast Sodium | 17 | $191 |
| Metformin Hcl | 18 | $174 |
| Estradiol | 16 | $152 |
| Escitalopram Oxalate | 15 | $147 |
| Carvedilol | 14 | $132 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Peoria
- David TrachtenbargPeoria$304K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.